Industry NewsAgendia Highlights Study Showing MammaPrint/BluePrint Tests Predict Response to Current Breast Cancer Chemotherapy and Targeted Therapy Regimens
Product NewsNew Data Published on PointMan™ DNA Enrichment Technology for Highly Sensitive Lung Cancer Mutation Detection
Industry NewsFirst UK Biobank Genetic Study Reveals New Associations with Lung Disease and Smoking Behavior